Your browser doesn't support javascript.
loading
Author Correction: Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer.
Sushentsev, Nikita; McLean, Mary A; Warren, Anne Y; Benjamin, Arnold J V; Brodie, Cara; Frary, Amy; Gill, Andrew B; Jones, Julia; Kaggie, Joshua D; Lamb, Benjamin W; Locke, Matthew J; Miller, Jodi L; Mills, Ian G; Priest, Andrew N; Robb, Fraser J L; Shah, Nimish; Schulte, Rolf F; Graves, Martin J; Gnanapragasam, Vincent J; Brindle, Kevin M; Barrett, Tristan; Gallagher, Ferdia A.
Afiliação
  • Sushentsev N; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • McLean MA; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Warren AY; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Benjamin AJV; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Brodie C; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Frary A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Gill AB; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Jones J; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Kaggie JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Lamb BW; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Locke MJ; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Miller JL; School of Allied Health, Anglia Ruskin University, Cambridge, UK.
  • Mills IG; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Priest AN; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Robb FJL; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Shah N; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Schulte RF; Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
  • Graves MJ; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Gnanapragasam VJ; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
  • Brindle KM; GE Healthcare, Aurora, OH, USA.
  • Barrett T; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Gallagher FA; GE Healthcare, Munich, Germany.
Nat Commun ; 13(1): 1274, 2022 Mar 07.
Article em En | MEDLINE | ID: mdl-35256616
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article